Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies
Open Access

Usability of a Reminder App that May Help to Reduce Radiotherapy-related Skin Toxicity in Patients With Breast Cancer

DIRK RADES, LIESA DZIGGEL, CARLOS A. NARVAEZ-WOLF, MAIKE RADTKE, CHRISTIAN STAACKMANN, HANNE SPANGSBERG HOLM and CHARLOTTE KRISTIANSEN
In Vivo May 2026, 40 (3) 1768-1775; DOI: https://doi.org/10.21873/invivo.14329
DIRK RADES
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany;
2Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Lübeck Campus, Lübeck, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dirk.rades{at}uksh.de
LIESA DZIGGEL
2Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Lübeck Campus, Lübeck, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CARLOS A. NARVAEZ-WOLF
2Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Lübeck Campus, Lübeck, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAIKE RADTKE
2Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Lübeck Campus, Lübeck, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHRISTIAN STAACKMANN
2Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Lübeck Campus, Lübeck, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HANNE SPANGSBERG HOLM
3Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHARLOTTE KRISTIANSEN
3Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: Patients irradiated for breast cancer may experience acute skin toxicity. To reduce this risk, a mobile application was created which reminds patients to carry out skin care. Before using this app in patients, a pre-study evaluating its usability in healthy volunteers was required.

Patients and Methods: In this prospective study, 30 healthy volunteers from Germany and Denmark were asked to test the app and complete a questionnaire including ten statements (“yes or “no”) in three sections.

Results: Satisfaction rates (statements affirmed with “yes”) were 66.7% (18/27 participants) and 78.6% (22/28) in the section “download and installation”, and 100% (29/29) and 96.7% (29/30) in the section “navigation”. In the section “content/functions”, the six statements were addressed by 28-30 participants; satisfaction rates were 86.7% to 100% (median 96.5%). Dichotomous responses were supplemented by individual comments.

Conclusion: This study revealed that the reminder app needed improvement before tested in patients and demonstrated the importance of a pre-study in healthy volunteers.

Keywords:
  • Breast cancer
  • radiotherapy
  • acute skin toxicity
  • reminder app
  • healthy volunteers

Introduction

Adjuvant radiotherapy following breast-conserving surgery is a standard local treatment for breast cancer (1, 2). In addition, post-operative irradiation may be required also after mastectomy if specific risk factors exist (1, 3). Radiotherapy for breast cancer may lead to significant acute skin toxicity, namely moderate or severe dermatitis, which can be quite burdensome for the affected patients (4, 5). To reduce this risk of radiation dermatitis, a mobile application was created that reminds patients four times a day to carry out specific skin care. However, before such a reminder app could be tested in patients irradiated for breast cancer, a pre-study evaluating its usability (functionality and practicability) in healthy volunteers was required. In line with other trials, the reminder app would be considered not useful if the satisfaction rate was less than 60% (6, 7). If this rate was between 60% and 80%, the app was considered useful but rated to require further development and optimization. The present prospective study was conducted in 30 healthy volunteers from Germany and Denmark who were recruited by project partners of the Interreg project Health Advancing Technologies for Elderly (HeAT). The study participants were asked to download the reminder app, to test it, and to complete a questionnaire including ten statements belonging to one of three different sections.

Patients and Methods

This prospective study included 30 healthy volunteers, 20 from Germany and 10 from Denmark. It was approved by the Ethics Committee at the University of Lübeck, Germany (2024-281_1) as part of the protocol of a randomized trial (8). The study participants were asked to download a reminder app developed by Nextlabel OHG, a company from Lübeck specialized in the development and design of software. The link for the app was provided by Nextlabel OHG via e-mail. Subsequently, the participants were asked to test the app and to complete a questionnaire, which was available in English, German, and Danish. After opening the app, the users were able to select their preferred language (English, German, or Danish). Afterwards, they received some information regarding the recommended skin care and skin protection to be performed during and after the course of radiotherapy. The users could define the times they would like to be reminded to carry out their skin care each day (four times a day, for example at 09:00 h, 12:00 h, 15:00 h, and 18:00 h). After being reminded, the users had to confirm each time via a button that they performed the required skin care. For every second of successful and confirmed performance, they received a puzzle piece as a kind of reward. Representative screen shots of the reminder app are given in Figure 1.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Representative screen shots of the reminder app.

The questionnaire consisted of ten statements that were categorized in three different sections, namely “download and installation” (two statements), “navigation” (two statements), and “content/functions” (six statements). The ten statements to be affirmed (“yes”) or negated (“no”) and the three sections are shown in Figure 2. In addition to addressing the statements in a dichotomous way, the participants could make individual comments. In line with previous trials, the reminder app was considered not useful if the satisfaction rate (rate of affirmed statements) was less than 60% (6-8). If this rate was between 60% and 80%, the app was considered useful but needed further optimization.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

The questionnaire to be completed by the study participants including the ten statements and the three sections.

Results

Four statements were addressed by all 30 participants, two statements by 29 participants, three statements by 28 participants, and one statement by 27 participants. In addition, 37 individual comments were provided by the participants related to the three sections, 17 comments related to the section “download and installation”, three comments to the section “navigation”, and 17 comments to the section “content/functions”. Twenty-two additional comments were not related to one of the sections.

The satisfaction rates were 66.7% (18 of 27 participants) and 78.6% (22 of 28 participants) in the section “download and installation”, and 100% (29 of 29 participants) and 96.7% (29 of 30 participants) in the section “navigation”, respectively (Table I). In the section “content/functions”, the six statements were addressed by 28 to 30 participants. In this section, the satisfaction rates ranged between 86.7% and 100% (median 96.5%).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Rates of affirmation (“yes”) and negation (“no”) of the ten statements regarding functionality and practicability of the reminder app.

The individual comments related to the section “download and installation” indicated problems with receiving the e-mail with the link or the download of the app (11 comments) and problems with the activation code/password (five comments). One comment mentioned that the program of the app “was in German at the start”. Of the three comments related to the section “navigation”, two were favorable (“easy to navigate - no problem”) and one stated problems with changing the language. The problem regarding the choice of the language was also mentioned in six comments related to the section “content/functions”. Five users missed or would like modifications of the information regarding skin care, five users indicated problems with the reminders, and one user just mentioned that he or she did not modify the times to be reminded.

Discussion

According to our previous study, 31.2% of 327 patients irradiated for breast cancer experienced at least moderate radiation dermatitis (9). The prevalence of moderate or severe radiation dermatitis in other studies ranged between 3% and 76% (10-31). Therefore, this acute toxicity can be considered a credible problem. It should also be avoided because it can impair the patients’ quality of life (4, 5). To reduce the risk of radiation dermatitis, the patients are asked to carry out specific skin care several times a day. However, the patients may find this challenging. Therefore, an app was created that provides instructions of skin care and skin protection during and following the course of radiotherapy (8). Moreover, this app reminds the patients four times a day of performing the required measures of skin care with specific cremes and lotions. Before the reminder app can be tested in prospective clinical trials involving patients irradiated for breast cancer, it needs to be evaluated with respect to functionality and practicability in a series of healthy volunteers. Therefore, this prospective study was conducted. Healthy volunteers from two countries completed a questionnaire of ten statements and added individual comments regarding their experience with the download and installation of the app, the navigation through the app, and its content and functions.

According to the findings of this study, the evaluated version of the reminder app required some improvement with respect to its download and installation. The satisfaction rates in this section were only 66.7% and 78.6%. Moreover, 17 individual comments were made in relation to the section “download and installation”. In the section “navigation”, the satisfaction rates were very high (100% and 96.7%, respectively). Of the three comments related to navigation, two comments were favorable and one comment that indicated problems with changing the language appeared more appropriate for the section “content/functions”. In that section, the satisfaction rates were >93% for five of the six statements. The corresponding rate for the statement “the app reminded me at the selected times” was also >80%. According to the pre-defined consequences based on satisfaction rates, modifications of this section of the app are not considered mandatory (8). However, when considering the individual comments related to this section, some improvements regarding the availability of the information regarding skin care and protection appear reasonable. The same applies to the language setting. The results of this study in healthy volunteers have led to modifications and further optimization of the reminder app.

In summary, this study revealed that the reminder app needed improvement. Moreover, our findings demonstrated that a pre-study in healthy volunteers is important to allow for further optimization of the app before it could be tested in a clinical trial including patients receiving local irradiation for breast cancer.

Acknowledgements

The study was partially funded by the European Regional Development Fund through the Interreg Deutschland-Danmark program (reference 01-1-23 2).

Footnotes

  • Authors’ Contributions

    All Authors are staff members of a project partner of the Interreg-project HeAT and participated in the design of the study and the collection of the data. The data were summarized by D.R. who also drafted the article. The article was reviewed and its final version approved by all Authors.

  • Conflicts of Interest

    The Authors are involved in the Interreg-project HeAT. Otherwise, no conflicts of interest exist in relation to this study.

  • Artificial Intelligence (AI) Disclosure

    No artificial intelligence (AI) tools, including large language models or machine learning software, were used in the preparation, analysis, or presentation of this manuscript.

  • Received February 18, 2026.
  • Revision received March 9, 2026.
  • Accepted March 18, 2026.
  • Copyright © 2026 The Author(s). Published by the International Institute of Anticancer Research.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

References

  1. ↵
    1. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF)
    : S3-Leitlinie Früherkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms, Version 4.4, 2021, AWMF Registernummer: 032-045OL. Available at: http://www.leitlinienprogramm-onkologie.de/leitlinien/mammakarzinom/ [Last accessed on February 18, 2026]
  2. ↵
    1. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG),
    2. Darby S,
    3. McGale P,
    4. Correa C,
    5. Taylor C,
    6. Arriagada R,
    7. Clarke M,
    8. Cutter D,
    9. Davies C,
    10. Ewertz M,
    11. Godwin J,
    12. Gray R,
    13. Pierce L,
    14. Whelan T,
    15. Wang Y,
    16. Peto R
    : Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet 378(9804): 1707-1716, 2011. DOI: 10.1016/s0140-6736(11)61629-2
    OpenUrlCrossRefPubMed
  3. ↵
    1. EBCTCG (Early Breast Cancer Trialists’ Collaborative Group),
    2. McGale P,
    3. Taylor C,
    4. Correa C,
    5. Cutter D,
    6. Duane F,
    7. Ewertz M,
    8. Gray R,
    9. Mannu G,
    10. Peto R,
    11. Whelan T,
    12. Wang Y,
    13. Wang Z,
    14. Darby S
    : Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 383(9935): 2127-2135, 2014. DOI: 10.1016/S0140-6736(14)60488-8
    OpenUrlCrossRefPubMed
  4. ↵
    1. Xie Y,
    2. Wang Q,
    3. Hu T,
    4. Chen R,
    5. Wang J,
    6. Chang H,
    7. Cheng J
    : Risk factors related to acute radiation dermatitis in breast cancer patients after radiotherapy: a systematic review and meta-analysis. Front Oncol 11: 738851, 2021. DOI: 10.3389/fonc.2021.738851
    OpenUrlCrossRefPubMed
  5. ↵
    1. Fuzissaki MA,
    2. Paiva CE,
    3. Oliveira MA,
    4. Lajolo Canto PP,
    5. Paiva Maia YC
    : The impact of radiodermatitis on breast cancer patients’ quality of life during radiotherapy: a prospective cohort study. J Pain Symptom Manage 58(1): 92-99.e1, 2019. DOI: 10.1016/j.jpainsymman.2019.03.017
    OpenUrlCrossRefPubMed
  6. ↵
    1. Rades D,
    2. Küter JD,
    3. von Staden M,
    4. Al-Salool A,
    5. Janssen S,
    6. Timke C,
    7. Duma MN,
    8. Bartscht T,
    9. Vestergård Madsen C,
    10. Kristiansen C,
    11. Cremers F
    : A reminder app to optimize bladder filling during radiotherapy for patients with prostate cancer (REFILL-PAC): protocol for a prospective trial. JMIR Res Protoc 14: e68179, 2025. DOI: 10.2196/68179
    OpenUrlCrossRef
  7. ↵
    1. Rades D,
    2. Küter JD,
    3. von Staden M,
    4. Al-Salool A,
    5. Ziemann C,
    6. Janssen S,
    7. Koeck J,
    8. Domschikowski J,
    9. Kristiansen C,
    10. Madsen CV,
    11. Duma MN,
    12. Bartscht T,
    13. Cacicedo J,
    14. Cremers F
    : Evaluation of reminder app for optimization of bladder filling status during hypo-fractionated irradiation for prostate cancer: protocol of REFILL-PAC-HYPO trial. Clin Pract 15(3): 40, 2025. DOI: 10.3390/clinpract15030040
    OpenUrlCrossRefPubMed
  8. ↵
    1. Rades D,
    2. Narvaez-Wolf CA,
    3. Dziggel L,
    4. Staackmann C,
    5. Radtke M,
    6. Timke C,
    7. Kristiansen C,
    8. Duma MN,
    9. Yu NY,
    10. Janssen S
    : Dermatitis during adjuvant irradiation for breast cancer (DAI-BREAC): a randomized controlled trial investigating whether grade ≥2 dermatitis during radiotherapy for breast cancer can be reduced by a mobile application that reminds patients to perform skin care. Trials 26(1): 99, 2025. DOI: 10.1186/s13063-025-08800-2
    OpenUrlCrossRefPubMed
  9. ↵
    1. Rades D,
    2. Kristiansen C,
    3. Timke C,
    4. Duma MN,
    5. Yu NY,
    6. Bartscht T,
    7. Janssen S
    : Clinically significant dermatitis during adjuvant radiotherapy for invasive breast cancer. Anticancer Res 44(4): 1525-1531, 2024. DOI: 10.21873/anticanres.16949
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Eggert MC,
    2. Yu NY,
    3. Rades D
    : Radiation dermatitis and pneumonitis in patients irradiated for breast cancer. In Vivo 37(6): 2654-2661, 2023. DOI: 10.21873/invivo.13374
    OpenUrlAbstract/FREE Full Text
    1. Phan C,
    2. Mindrum M,
    3. Silverman C,
    4. Paris K,
    5. Spanos W
    : Matched-control retrospective study of the acute and late complications in patients with collagen vascular diseases treated with radiation therapy. Cancer J 9(6): 461-466, 2003. DOI: 10.1097/00130404-200311000-00005
    OpenUrlCrossRefPubMed
    1. Freedman GM,
    2. Li T,
    3. Nicolaou N,
    4. Chen Y,
    5. Ma CC,
    6. Anderson PR
    : Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation. Int J Radiat Oncol Biol Phys 74(3): 689-694, 2009. DOI: 10.1016/j.ijrobp.2008.08.071
    OpenUrlCrossRefPubMed
    1. Kraus-Tiefenbacher U,
    2. Sfintizky A,
    3. Welzel G,
    4. Simeonova A,
    5. Sperk E,
    6. Siebenlist K,
    7. Mai S,
    8. Wenz F
    : Factors of influence on acute skin toxicity of breast cancer patients treated with standard three-dimensional conformal radiotherapy (3D-CRT) after breast conserving surgery (BCS). Radiat Oncol 7: 217, 2012. DOI: 10.1186/1748-717X-7-217
    OpenUrlCrossRefPubMed
    1. Tortorelli G,
    2. Di Murro L,
    3. Barbarino R,
    4. Cicchetti S,
    5. di Cristino D,
    6. Falco MD,
    7. Fedele D,
    8. Ingrosso G,
    9. Janniello D,
    10. Morelli P,
    11. Murgia A,
    12. Ponti E,
    13. Terenzi S,
    14. Tolu B,
    15. Santoni R
    : Standard or hypofractionated radiotherapy in the postoperative treatment of breast cancer: a retrospective analysis of acute skin toxicity and dose inhomogeneities. BMC Cancer 13: 230, 2013. DOI: 10.1186/1471-2407-13-230
    OpenUrlCrossRefPubMed
    1. Ciammella P,
    2. Podgornii A,
    3. Galeandro M,
    4. Micera R,
    5. Ramundo D,
    6. Palmieri T,
    7. Cagni E,
    8. Iotti C
    : Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors. Radiat Oncol 9: 97, 2014. DOI: 10.1186/1748-717X-9-97
    OpenUrlCrossRefPubMed
    1. Karasawa K,
    2. Kunogi H,
    3. Hirai T,
    4. Hojo H,
    5. Hirowatari H,
    6. Izawa H,
    7. Ito K,
    8. Sasai K,
    9. Kawashima M,
    10. Furuya T,
    11. Sugimoto S,
    12. Kurokawa C,
    13. Ozawa S,
    14. Saito M
    : Comparison of hypofractionated and conventionally fractionated whole-breast irradiation for early breast cancer patients: a single-institute study of 1,098 patients. Breast Cancer 21(4): 402-408, 2014. DOI: 10.1007/s12282-012-0406-6
    OpenUrlCrossRefPubMed
    1. De Langhe S,
    2. Mulliez T,
    3. Veldeman L,
    4. Remouchamps V,
    5. van Greveling A,
    6. Gilsoul M,
    7. De Schepper E,
    8. De Ruyck K,
    9. De Neve W,
    10. Thierens H
    : Factors modifying the risk for developing acute skin toxicity after whole-breast intensity modulated radiotherapy. BMC Cancer 14: 711, 2014. DOI: 10.1186/1471-2407-14-711
    OpenUrlCrossRefPubMed
    1. Jagsi R,
    2. Griffith KA,
    3. Boike TP,
    4. Walker E,
    5. Nurushev T,
    6. Grills IS,
    7. Moran JM,
    8. Feng M,
    9. Hayman J,
    10. Pierce LJ
    : Differences in the acute toxic effects of breast radiotherapy by fractionation schedule. JAMA Oncol 1(7): 918, 2015. DOI: 10.1001/jamaoncol.2015.2590
    OpenUrlCrossRefPubMed
    1. Aoulad N,
    2. Massabeau C,
    3. de Lafontan B,
    4. Vieillevigne L,
    5. Hangard G,
    6. Ciprian C,
    7. Chaltiel L,
    8. Moyal É,
    9. Izar F
    : [Acute toxicity of breast cancer irradiation with modulated intensity by tomotherapy®]. Cancer Radiother 21(3): 180-189, 2017. DOI: 10.1016/j.canrad.2016.11.008
    OpenUrlCrossRefPubMed
    1. De Santis MC,
    2. Bonfantini F,
    3. Di Salvo F,
    4. Dispinzieri M,
    5. Mantero E,
    6. Soncini F,
    7. Baili P,
    8. Sant M,
    9. Bianchi G,
    10. Maggi C,
    11. Di Cosimo S,
    12. Agresti R,
    13. Pignoli E,
    14. Valdagni R,
    15. Lozza L
    : Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy. Breast 29: 90-95, 2016. DOI: 10.1016/j.breast.2016.07.013
    OpenUrlCrossRefPubMed
    1. Ding J,
    2. Guo Y,
    3. Li Q,
    4. Chen J,
    5. Hu P,
    6. Liu Q,
    7. Cao Y,
    8. Wu J
    : The incidence of postoperative radiotherapy-induced acute dermatitis in breast cancer and its influencing factors for Chinese women. Onco Targets Ther 11: 1665-1670, 2018. DOI: 10.2147/OTT.S156066
    OpenUrlCrossRefPubMed
    1. Akl FMF,
    2. Khater A
    : Hypofractionated versus conventionally fractionated radiotherapy in post-mastectomy breast cancer patients. J Cancer Ther 09(11): 941-954, 2018. DOI: 10.4236/jct.2018.911078
    OpenUrlCrossRef
    1. Kawaguchi H,
    2. Tsujino K,
    3. Miki M,
    4. Matsumoto Y,
    5. Ota Y,
    6. Hirokaga K,
    7. Takao S,
    8. Soejima T,
    9. Sasaki R
    : Patient preference study comparing hypofractionated versus conventionally fractionated whole-breast irradiation after breast-conserving surgery. Jpn J Clin Oncol 49(6): 545-553, 2019. DOI: 10.1093/jjco/hyz003
    OpenUrlCrossRefPubMed
    1. Butler-Xu YS,
    2. Marietta M,
    3. Zahra A,
    4. TenNapel M,
    5. Mitchell M
    : The effect of breast volume on toxicity using hypofractionated regimens for early stage breast cancer for patients. Adv Radiat Oncol 4(2): 261-267, 2018. DOI: 10.1016/j.adro.2018.10.005
    OpenUrlCrossRefPubMed
    1. Chen CH,
    2. Hsieh CC,
    3. Chang CS,
    4. Chen MF
    : A retrospective analysis of dose distribution and toxicity in patients with left breast cancer treated with adjuvant intensity-modulated radiotherapy: comparison with three-dimensional conformal radiotherapy. Cancer Manag Res Volume 12: 9173-9182, 2020. DOI: 10.2147/cmar.S269893
    OpenUrlCrossRef
    1. Abdeltawab AA,
    2. Ali SA,
    3. Mostafa HG,
    4. Hassan MA
    : Predictive factors increasing the risk of radiation toxicity in patients with early breast cancer. Asian Pac J Cancer Prev 22(1): 145-149, 2021. DOI: 10.31557/apjcp.2021.22.1.145
    OpenUrlCrossRefPubMed
    1. Pasquier D,
    2. Bataille B,
    3. Le Tinier F,
    4. Bennadji R,
    5. Langin H,
    6. Escande A,
    7. Tresch E,
    8. Darloy F,
    9. Carlier D,
    10. Crop F,
    11. Lartigau E
    : Correlation between toxicity and dosimetric parameters for adjuvant intensity modulated radiation therapy of breast cancer: a prospective study. Sci Rep 11(1): 3626, 2021. DOI: 10.1038/s41598-021-83159-3
    OpenUrlCrossRefPubMed
    1. Liu D,
    2. Zheng Z,
    3. Zhang S,
    4. Zhu C,
    5. Zhang H,
    6. Zhou Y
    : Analysis of risk factors related to acute radiation dermatitis in breast cancer patients during radiotherapy. J Cancer Res Ther 18(7): 1903-1909, 2022. DOI: 10.4103/jcrt.jcrt_1203_22
    OpenUrlCrossRefPubMed
    1. Bruand M,
    2. Salleron J,
    3. Guihard S,
    4. Crety CM,
    5. Liem X,
    6. Pasquier D,
    7. Lamrani-Ghaouti A,
    8. Charra-Brunaud C,
    9. Peiffert D,
    10. Clavier JB,
    11. Desandes E,
    12. Faivre JC
    : Acute skin toxicity of conventional fractionated versus hypofractionated radiotherapy in breast cancer patients receiving regional node irradiation: the real-life prospective multicenter HYPOBREAST cohort. BMC Cancer 22(1): 1318, 2022. DOI: 10.1186/s12885-022-10402-z
    OpenUrlCrossRefPubMed
    1. Xie Y,
    2. Hu T,
    3. Chen R,
    4. Chang H,
    5. Wang Q,
    6. Cheng J
    : Predicting acute radiation dermatitis in breast cancer: a prospective cohort study. BMC Cancer 23(1): 537, 2023. DOI: 10.1186/s12885-023-10821-6
    OpenUrlCrossRefPubMed
  11. ↵
    1. Wei TN,
    2. Yeh HL,
    3. Lin JF,
    4. Hung CC
    : The clinical outcome of postoperative radiotherapy using hybrid planning technique in left breast cancer after breast-conserving surgery. Cancer Med 12(5): 5364-5371, 2023. DOI: 10.1002/cam4.5358
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

In Vivo: 40 (3)
In Vivo
Vol. 40, Issue 3
May-June 2026
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Usability of a Reminder App that May Help to Reduce Radiotherapy-related Skin Toxicity in Patients With Breast Cancer
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Usability of a Reminder App that May Help to Reduce Radiotherapy-related Skin Toxicity in Patients With Breast Cancer
DIRK RADES, LIESA DZIGGEL, CARLOS A. NARVAEZ-WOLF, MAIKE RADTKE, CHRISTIAN STAACKMANN, HANNE SPANGSBERG HOLM, CHARLOTTE KRISTIANSEN
In Vivo May 2026, 40 (3) 1768-1775; DOI: 10.21873/invivo.14329

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Usability of a Reminder App that May Help to Reduce Radiotherapy-related Skin Toxicity in Patients With Breast Cancer
DIRK RADES, LIESA DZIGGEL, CARLOS A. NARVAEZ-WOLF, MAIKE RADTKE, CHRISTIAN STAACKMANN, HANNE SPANGSBERG HOLM, CHARLOTTE KRISTIANSEN
In Vivo May 2026, 40 (3) 1768-1775; DOI: 10.21873/invivo.14329
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Evaluation of Cement Leakage and Complications After Cement-augmented Pedicle Screw Fixation: A Retrospective Case Series
  • Comparison of Early Response to Selumetinib Therapy in Adolescents and Children With NF1-related Plexiform Neurofibromas
  • Association Between Dipeptidyl Peptidase-4 Inhibitor Use and Acute Kidney Injury in Patients With Diabetes Mellitus: A Disproportionality Analysis Based on the FAERS
Show more Clinical Studies

Keywords

  • breast cancer
  • radiotherapy
  • acute skin toxicity
  • reminder app
  • healthy volunteers
In Vivo

© 2026 In Vivo

Powered by HighWire